Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Köhler Pharma is a specialized German pharmaceutical company recognized globally for its expertise in organ protection and therapeutic mineral supplementation. The company's flagship product, Custodiol HTK Solution, is a gold standard in transplant medicine and cardiac surgery, used to preserve organs during transport and protect the heart during complex procedures. In addition to its surgical portfolio, Köhler Pharma develops and markets a wide range of high-quality mineral and trace element preparations, including Unizink and Magnesium Köhler. Founded in 1954, the company remains an independent, family-owned enterprise dedicated to providing essential solutions for intensive care, surgery, and metabolic health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koehler Pharmaceuticals.